- Patrick Gleason PharmD, Senior Director of Health Outcomes, Prime Therapeutics.
Excerpted from: Value Based Payment News, Volume 2 Issue 20, October Second Edition 2017, "NAACOS, Leavitt See ACOs ‘Slowly’ Accepting Risk."
 |
Health Economics and Outcomes Research in the Era of Value-Based
Care and the 21st Century Cures Act
A panel discussion focused on how the 21st Cures Act has
increased focus on real-world evidence (RWE), from an
educational symposium sponsored by Cardinal Health during the
22nd Annual ISPOR International Meeting. Within oncology,
regulatory issues limit clinical trial participation to 3% of
cancer patients who differ from the real-world population.
However, RWE is criticized for inadequacies in validating drug
label expansions. New methods to address these challenges are
discussed. |
Check out
HealthshareTV, the
home for health care videos |
|
Joseph Antos: 5 principles of
value-based care 1. We have to find a way to move from simple-minded fee-for-service. 2. Providers have to integrate care delivery. 3. Continue reading here Source: Healthcare IT News |
||
- Prime Research Questions Cost Savings from Value-Based Insurance Designs
- NAACOS, Leavitt See ACOs ‘Slowly’ Accepting Risk
- Industry News with briefs regarding: Humana, PatientPing, WellCare
- Click here to subscribe to Value-Based Payment News, or find out more
|